The global formulation development outsourcing market size was valued at $22.5 billion in 2021, and is projected to reach $51.9 billion by 2031, growing at a CAGR of 9% from 2022 to 2031. The ...

One of the goals of any oral formulation development project is to create a formulation in which the active pharmaceutical ingredient (API) is sufficiently bioavailable to have the desired therapeutic ...

Accelerated formulation strategies are a useful tool to reduce development timelines and cost, but key priorities must be considered early on to ensure success. Although approximations vary ...

Artificial intelligence and machine learning can help overcome poor solubility and bioavailability. Artificial intelligence (AI) and machine learning (ML) in the biopharmaceutical industry have been ...

Modeling and simulation (M&S) has already profoundly impacted drug development and formulation. It is used in 90% of all U.S. Food and Drug Administration (FDA) drug approvals. M&S can influence every ...

As a contract research and development biotechnology firm, CD Formulation establishes new benchmarks for health care product development by delivering extensive product formulation services. From ...

Poor solubility is a major challenge for drug sponsors, as the development process is often stalled due to a drug candidate's low aqueous solubility, leading to difficulties in formulation and reduced ...

ALBANY, N.Y.--(BUSINESS WIRE)--Curia, formerly AMRI, a leading contract research, development and manufacturing organization, today announced it has entered into a definitive agreement to acquire ...